HeartFlow, Inc. HTFL 深 沪
已收盘 02-06 16:00:00 美东时间
27.74
+1.750
+6.73%
华盛通- 最 高28.41
- 今 开25.99
- 成交量 292.69万股
- 最 低 25.60
- 昨 收 25.99
- 总市值 22.52亿
- 52周最高 41.2231
- 市盈率 静 --
- 换手率 3.61%
- 52周最低 25.38
- 委 比 -91.34%
- 总股本 8116.84万
- 历史最高 41.2231
- 量 比 1.05
- 振 幅 10.81%
- 历史最低 25.38
- 每 手 1
- 风险率 3.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
Wells Fargo Initiates Coverage On HeartFlow with Overweight Rating, Announces Price Target of $38
Wells Fargo analyst Larry Biegelsen initiates coverage on HeartFlow (NASDAQ:HTFL) with a Overweight rating and announces Price Target of $38.
01-28 20:50
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 bi...
2025-12-12 22:49
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
2025-11-14 10:43
Stifel Maintains Buy on HeartFlow, Raises Price Target to $40
Stifel analyst Rick Wise maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $35 to $40.
2025-11-14 00:13
Heartflow shares are trading lower after the company reported mixed Q3 financial results.
Heartflow shares are trading lower after the company reported mixed Q3 financia...
2025-11-13 23:35
HeartFlow Sees FY2025 Sales $173.000M-$173.500M vs $165.900M Est
HeartFlow (NASDAQ:HTFL) sees FY2025 sales of $173.000 million-$173.500 million vs $165.900 million analyst estimate.
2025-11-13 06:59
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
Alpha Buying: 118 Years of Finding World-Changing Stocks
Back in August when the 14F filings deadline had passed I wrote about some of t...
2025-11-07 01:16
Heartflow To Present New Late-Breaking Data Highlighting Clinical And Economic Value Of Heartflow Plaque Analysis At AHA Scientific Sessions 2025
Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic value of Heartflow
2025-11-03 21:05
